Recursive Superintelligence raises $500M to accelerate AI innovation, signaling strong investor confidence in next-gen intelligence systems.
Hosted on MSN
Anthropic warns of early signs of AI building itself
Anthropic says it is witnessing early indications of artificial intelligence systems contributing to their own advancement, a process called recursive self‑improvement. Co‑founder Jack Clark estimates ...
On Aug. 8, Recursion Pharmaceuticals announced its intention to merge with Exscientia in an all-stock deal. Recursion Pharmaceuticals and Exscientia are both pharma-tech companies that aim to improve ...
Chris Gibson, Recursion Pharmaceuticals CEO, joins 'Closing Bell Overtime' to talk its partnership with Nvidia, its investors day, drug discovery and more. Got a confidential news tip? We want to hear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results